Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

66

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

66 results for “tumor-infiltrating lymphocytes”

Learn how ShareScore rates datasets ↗
geo16/100

Tet2 inactivation enhances the anti-tumor activity of tumor-infiltrating lymphocytes

GEO Series GSE152496. Mus musculus. 20 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenApr 2021View details →
geo16/100

Single-cell RNA sequencing (scRNA-Seq) analysis of tumor-infiltrating lymphocytes (TILs) from B16-F0 melanoma in mice

GEO Series GSE298324. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2026View details →
zenodo16/100

Dataset related to article "Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery."

<p>BACKGROUND:</p> <p>Immune infiltrate impacts prognosis of several tumors. To assess the prognostic impact of tumor-infiltrating lymphocytes and macrophages in patients undergoing resection for intrahepatic cholangiocellular carcinoma (ICC).</p> <p>METHODS:</p> <p>All consecutive patients undergoing surgery for ICC between 2008 and 2016 were considered. Inclusion criteria were complete resection and follow-up &gt;&thinsp;12&nbsp;months. Tissue sections were immunostained for CD3+, CD4+, CD8+, Foxp3+, and CD68+. The number of positive cells was quantified using a computer-aided image analysis system. Different cut-off values were tested as predictors of overall survival (OS).</p> <p>RESULTS:</p> <p>Fifty-three patients were analyzed. ICC were T1 in 28 patients, multifocal in 11, and N+ in 13. After a median follow-up of 42&nbsp;months, 5-year OS was 52.1%. The following immune infiltrate values were associated with better OS: CD3+ &gt;&thinsp;0.10% (5-year OS 63.3% vs. 13.6% if &le;&thinsp;0.10%, p&nbsp;=&thinsp;0.001); CD8+ &gt;&thinsp;0.10% (56.2% vs. 28.6% if &le;&thinsp;0.10%, p&nbsp;=&thinsp;0.051); Foxp3+ absent (59.4% vs. 16.0% if present, p&nbsp;=&thinsp;0.049). CD4+ and CD68+ infiltrates were not associated with OS. Three-year OS rates in patients with 0, 1, and &ge;&thinsp;2 negative prognostic factors were 73.6%, 47.3%, and 14.3%, respectively (p&nbsp;&lt;&thinsp;0.001). CD3+ infiltrate stratified prognosis in T1 tumors (3-year OS 71.7% if CD3+ &gt;&thinsp;0.10% vs. 14.3% if &le;&thinsp;0.10%, p&nbsp;&lt;&thinsp;0.001).</p> <p>CONCLUSIONS:</p> <p>Tumor-infiltrating lymphocytes are associated with prognosis of ICC patients after complete surgery. CD3+ and CD8+ infiltrate is associated with higher survival and lower recurrence risk, while Foxp3+ infiltrate is associated with worse prognosis. CD3+ infiltrate allows refining prediction of prognosis in early tumors.</p>

restrictedMar 2020View details →
geo12/100

Single-cell transcriptome analysis reveals functional changes in tumor-infiltrating B lymphocytes after chemotherapy in esophageal squamous cell carcinoma

GEO Series GSE199619. Homo sapiens. 7 samples. Type: Expression profiling by high throughput sequencing; Third-party reanalysis.

openGEO-OpenMay 2023View details →
zenodo12/100

Dataset related to article "Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression"

<p>The densities of CD3<sup>+</sup> and CD8<sup>+</sup> tumor-infiltrating lymphocytes (TILs), combined with tumor-node-metastasis (TNM) staging, have prognostic value for patients with nonmetastatic colorectal cancer. We compared the prognostic value of CD3<sup>+</sup> and FoxP3<sup>+</sup> TILs at the invasive front, TNM classifiers, and microsatellite (MS) status in a trial set of patients with stage II and III colorectal cancer (<em>n</em> = 413), by recursive partitioning with a classification and regression tree (CART). Significant prognostic factors and interactions were reassessed by logistic regression and Cox proportional-hazards modeling in the trial and a validation set (<em>n</em> = 215) of patients with stage II colorectal cancer. In the trial set, CART indicated that TIL numbers were of value only in predicting recurrence risk for stage II cancers, where low densities of FoxP3<sup>+</sup> TILs ranked first and low densities of CD3<sup>+</sup> TILs further stratifying risk. Multivariate analysis showed that TILs interacted with tumor stage (FoxP3<sup>+</sup>, <em>P</em> = 0.06; CD3<sup>+</sup>, <em>P</em> = 0.02) and MS instability (MSI; FoxP3<sup>+</sup>; <em>P</em> = 0.02). In stage II MS-stable cancers, concomitant low densities of both FoxP3<sup>+</sup> and CD3<sup>+</sup> TILs identified patients with the highest progression risk in the trial [HR 7.24; 95% confidence interval (CI), 3.41-15.4; <em>P</em> &lt; 0.001] and the validation (HR 15.16; 95% CI, 3.43-66.9; <em>P</em> &lt; 0.001) sets. FoxP3<sup>+</sup> and CD3<sup>+</sup> TIL load in colorectal cancer was more informative than other prognostic factors before the cancer progressed to lymph nodes. This prognostic information about TILs, including FoxP3<sup>+</sup> cells, suggests that randomized controlled trials might be refined to include interactions between TNM status, molecular classifiers, and postsurgical treatments.</p>

restrictedMar 2020View details →
geo12/100

EZH2 protects tumor-infiltrating lymphocytes from metabolic-stress induced cell death and exhaustion

GEO Series GSE142454. Mus musculus. 6 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenDec 2020View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record